Amity University Rajasthan successfully hosted E-SUMMIT 2025, a three-day mega event dedicated to fostering innovation, ...
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
With Q3 behind us, let’s have a look at ANI Pharmaceuticals (NASDAQ:ANIP) and its peers. The generic pharmaceutical industry operates on a volume-driven, low-cost business model, producing ...
ANI Pharmaceuticals (NASDAQ:ANIP – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating ...
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at ANI Pharmaceuticals (NASDAQ:ANIP) and its peers. The generic ...
PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani ...
Is ANI Pharmaceuticals (ANIP) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
In a report released today, Les Sulewski from Truist Financial maintained a Hold rating on Bausch Health Companies (BHC – Research Report). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results